B.T. Li
0000-0002-7300-5027
Publication & Citation Trends
Publications
29 total
103TiP Sotorasib versus pembrolizumab in combination with platinum doublet chemotherapy as first-line treatment for metastatic or locally advanced, PD-L1 negative, KRAS G12C-mutated NSCLC (CodeBreaK 202) PDF
Cited by 4
OpenAlex
1305P Sotorasib long-term clinical outcomes in pretreated KRAS G12C-mutated advanced NSCLC: Pooled analysis from the CodeBreaK clinical trials
Cited by 0
Semantic Scholar
293P Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
Cited by 3
Semantic Scholar
645P Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
Cited by 1
Semantic Scholar
1321MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02 PDF
Cited by 32
OpenAlex
MA06.05 CodeBreaK 101: Safety and Efficacy of Sotorasib with Carboplatin and Pemetrexed in KRAS G12C-Mutated Advanced NSCLC PDF
Cited by 13
OpenAlex
657MO Recommended phase II dose (RP2D) selection and pharmacodynamic (PD) data of the first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients (pts) with advanced HER2-expressing solid tumors PDF
Cited by 5
OpenAlex
P2.10-06 Brain Metastases in Patients with Fusion-Positive Lung Cancers OA
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(17)
Colorectal Cancer Treatments and Studies
(8)
Cancer Genomics and Diagnostics
(8)
Lung Cancer Research Studies
(8)
HER2/EGFR in Cancer Research
(6)
Affiliations
Memorial Sloan Kettering Cancer Center
Cornell University
Kettering University
Affiliated Hospital of Shaanxi University of Chinese Medicine
Shaanxi University of Chinese Medicine